As of 2024-12-14, the Relative Valuation of Oric Pharmaceuticals Inc (ORIC) is (30.83) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.43 USD, the upside of Oric Pharmaceuticals Inc based on Relative Valuation is -465.7%.
The range of the Relative Valuation is (19.23) - (32.48) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.5x - 24.4x | 17.5x |
| Forward P/E multiples | 11.3x - 19.1x | 18.8x |
| Fair Price | (19.23) - (32.48) | (30.83) |
| Upside | -328.1% - -485.3% | -465.7% |
| Date | P/E |
| 2024-11-29 | -5.83 |
| 2024-11-27 | -5.87 |
| 2024-11-26 | -5.77 |
| 2024-11-25 | -5.81 |
| 2024-11-22 | -5.65 |
| 2024-11-21 | -5.37 |
| 2024-11-20 | -5.15 |
| 2024-11-19 | -5.23 |
| 2024-11-18 | -5.04 |
| 2024-11-15 | -5.00 |
| 2024-11-14 | -5.20 |
| 2024-11-13 | -6.05 |
| 2024-11-12 | -6.04 |
| 2024-11-11 | -6.06 |
| 2024-11-08 | -6.04 |
| 2024-11-07 | -5.86 |
| 2024-11-06 | -6.06 |
| 2024-11-05 | -5.70 |
| 2024-11-04 | -5.58 |
| 2024-11-01 | -5.54 |
| 2024-10-31 | -5.52 |
| 2024-10-30 | -5.55 |
| 2024-10-29 | -5.30 |
| 2024-10-28 | -4.97 |
| 2024-10-25 | -4.80 |
| 2024-10-24 | -4.97 |
| 2024-10-23 | -5.19 |
| 2024-10-22 | -5.13 |
| 2024-10-21 | -5.37 |
| 2024-10-18 | -5.56 |
| 2024-10-17 | -5.39 |
| 2024-10-16 | -5.68 |
| 2024-10-15 | -5.60 |
| 2024-10-14 | -5.62 |
| 2024-10-11 | -5.49 |
| 2024-10-10 | -5.46 |
| 2024-10-09 | -5.46 |
| 2024-10-08 | -5.59 |
| 2024-10-07 | -5.59 |
| 2024-10-04 | -5.66 |
| 2024-10-03 | -5.62 |
| 2024-10-02 | -5.76 |
| 2024-10-01 | -5.91 |
| 2024-09-30 | -6.03 |
| 2024-09-27 | -6.27 |
| 2024-09-26 | -6.10 |
| 2024-09-25 | -5.89 |
| 2024-09-24 | -6.33 |
| 2024-09-23 | -6.32 |
| 2024-09-20 | -6.62 |